CDK1 and breast cancer: Anti-differentiation non-coding RNA (lncRNA ANCR) suppresses breast cancer progression by promoting the cyclin dependent kinase 1 (CDK1)-mediated phosphorylation and degradation of EZH2 [70] (Figure 4D).